Biden DXM Bill Includes Age Limit, Bulk Ingredient Scheduling
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association backs Sen. Joe Biden's proposal to set a nationwide age limit on purchases of dextromethorphan-containing OTC drugs, but the group differs with the bill's approach to regulating bulk sales of raw DXM
You may also be interested in...
“Snurf” Abuse Reports Revive Interest In DXM Bills
A recent report of young people suspected of abusing "Snurf" has reignited interest on Capitol Hill in restricting bulk purchases of raw dextromethorphan and an age restriction on OTCs containing the cough suppressant
“Snurf” Abuse Reports Revive Interest In DXM Bills
A recent report of young people suspected of abusing "Snurf" has reignited interest on Capitol Hill in restricting bulk purchases of raw dextromethorphan and an age restriction on OTCs containing the cough suppressant
“Snurf” Abuse Reports Revive Interest In DXM Bills
A recent report of young people suspected of abusing "Snurf" has reignited interest on Capitol Hill in restricting bulk purchases of raw dextromethorphan and an age restriction on OTCs containing the cough suppressant